Search Results 1541-1550 of 18730 for Relapse
Mayo Clinic to offer CAR T-cell therapy for relapsed non-Hodgkin lymphoma featured. Cancer. Mayo Clinic to offer CAR T-cell therapy for relapsed non-Hodgkin ...
Study shows drug reduces risk of relapse with neuromyelitis optica featured image. Featured News. Study shows drug reduces risk of relapse with neuromyelitis ...
In the phase I study, the researchers gave nivolumab every two weeks to 23 patients with relapsed or refractory Hodgkin's lymphoma who were heavily pretreated.
AZD0486 As Monotherapy In Participants With Relapsed/Refractory (R/R) B-cell NHL. Rochester, Minn. This is a Phase 2 global, multi-center, open-label study ...
Educational components of the program include stress management, relapse prevention, nutrition, wellness and medical complications resulting from tobacco use.
Phase II will study how well the the treatment works in patients with previously treated (relapsed or refractory) multiple myeloma and kidney dysfunction.
This is a Phase 2, open-label, 2-part, multicenter study in subjects with MSS relapsed/refractory colorectal cancer. The primary objective of Part 1 is to ...
... relapse in January 2015. Her treatment options were limited, because of all ... Things didn't improve right away for Christina. When she relapsed in ...
Post-transplant relapse of cancer; Active progressive CHRONIC chronic or overlap GVHD (per the NIH chronic GVHD criteria); Presence of uncontrolled ...
Has previously received avacopan for treatment of GPA/MPA (including relapse) for at least 30 days. Prior discontinuation of avacopan because of an adverse ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.